Filter by
NewsNew Holistic Beauty Publication with Cerebiome For Gut-Brain-Skin Axis Mirabel, February 10, 2025 – Lallemand Health Solutions is proud to announce the latest findings from a comprehensive study on Cerebiome®, a pioneering psychobiotic developed by the Rosell® Institute for Microbiome and Probiotics. This innovative formula has shown significant benefits […]
Feb 7, 2025
NewsThe International Conference on Microbiota-Gut-Brain Axis Returns!Mirabel, February 1, 2025 – Lallemand Health Solutions, as co-founding partner, proudly announces the fifth edition of the Mind, Mood & Microbes International Conference on the microbiota-gut-brain axis. This event will be held in Amsterdam, the Netherlands, on February 11-12, […]
Jan 29, 2025
NewsLallemand Health Solutions Achieves ISO 14001 Certification for its Saint-Simon PlantMirabel, Canada, January 6, 2025 – The French bacteria production plant located in Saint-Simon (Aurillac) of Lallemand Health Solutions has just obtained ISO 14001 certification, thus confirming the integration of environmental concerns into its daily activities while maintaining its operational […]
Jan 7, 2025
NewsLallemand Health Solutions Welcomes Biotechnology Students from Collège Ahuntsic for a Tour of Its Facilities Mirabel, Canada, November 11, 2024 – Lallemand Health Solutions recently welcomed about 60 students from the biotechnology program at Collège Ahuntsic in Montreal to its facilities in Mirabel. This event allowed students to discover this family-owned company, founded in Montreal over […]
Nov 13, 2024
NewsLallemand Health Solutions Presents Its Latest Scientific Breakthroughs at SupplySide West 2024Mirabel, Canada, October 1, 2024 – Lallemand Health Solutions is excited to present its latest scientific advancements at SupplySide West 2024, taking place in Las Vegas, USA, on October 30-31, 2024. Discover Prenatis: Nurturing Life, From Mom to Baby Elodie […]
Oct 7, 2024
NewsLallemand Health Solutions Launches a Groundbreaking Clinical Study of Probiotic Efficacy on SIBO Using the SIMBA Capsule for Direct Sampling of the Small Intestine.Montreal, September 10, 2024 – Lallemand Health Solutions announces the regulatory and ethics committee approval of their double-blind, randomized, placebo-controlled clinical study in patients with Small Intestinal Bacterial Overgrowth (SIBO). With this study, Lallemand Health Solutions positions itself as a […]
Sep 10, 2024
NewsLallemand inaugurates new research and development laboratoriesBlagnac, France, September 4, 2024 – Lallemand proudly announces the inauguration of its new laboratories in France, increasing its capacity by over 800 square meters. This significant expansion enhances its interdisciplinary research and development capabilities at the Blagnac and Beauzelle […]
Sep 4, 2024
NewsSubscribe To the New Newsletter: My Mind Mood & Microbes To Learn More About the Microbiota-Gut-Brain AxisAs a co-founding partner with Winclove of the Mind, Mood & Microbes (MMM) International Conference on the Microbiota-Gut-Brain axis, Lallemand Health Solutions proudly supports the launch of a newsletter, named myMMM (myMindMoodMicrobes) to bring gut-brain research to a wider audience. […]
Jul 5, 2024
NewsLallemand Health Solutions Presents Cutting-Edge Innovations at Vitafoods Europe 2024Lallemand Health Solutions is thrilled to showcase its latest breakthroughs at Vitafoods Europe 2024 held in Geneva, Switzerland, from May 14 to 16, 2024. Discover Prenatis: Nurturing Life, From Mom to BabyElodie Aragon, Product Manager at Lallemand Health Solutions shares […]
May 2, 2024
NewsLallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic SolutionsLallemand Health Solutions and dsm-firmenich are joining forces to launch early-life synbiotic solutions, leveraging the synergy of probiotics and human milk oligosaccharides (HMOs). Unlocking the synergy between probiotics and HMOs to provide infants with the best of start, Lallemand Health […]
Apr 24, 2024